Epinastine
From Self-sufficiency
File:Epinastine.svg | |
Systematic (IUPAC) name | |
---|---|
(RS)-3-amino-9,13b-dihydro-1H- dibenz(c,f)imidazo(1,5-a)azepine | |
Clinical data | |
Pregnancy category |
|
Routes of administration | Eye drops |
Pharmacokinetic data | |
Protein binding | 64% |
Biological half-life | 12 hours |
Identifiers | |
CAS Number | 80012-43-7 |
ATC code | R06AX24 (WHO) S01GX10 |
PubChem | CID 3241 |
DrugBank | APRD00043 |
Chemical data | |
Formula | C16H15N3 |
Molar mass | 249.311 g/mol[[Script error: No such module "String".]] |
(verify) |
Epinastine (trade names Elestat and Relestat) is an antihistamine and a mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis. It is presently produced by Allergan and marketed by Inspire in the United States.[1] It is used as the hydrochloride salt.
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ Pradhan, S; Abhishek, K; Mah, F (2009). "Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects". Expert opinion on drug metabolism & toxicology. 5 (9): 1135–40. doi:10.1517/17425250903117284. PMID 19630694.
Categories:
- Pages using duplicate arguments in template calls
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Dibenzimidazazepines
- H1 receptor antagonists
- Pharmacology stubs
- 2Fix